Re-Vana Therapeutics is an ocular pharmaceutical​ and drug delivery company focused on the development and commercialisation of revolutionary long-acting biodegradable drug delivery platforms to treat chronic eye diseases such as age-related macular degeneration, diabetic retinopathy, glaucoma and ocular infections.


Pharmaceutical

Re-Vana Therapeutics

Michael O’rourke

Wenrui Zhang

Sandip Gite

Shivanki Sahay

Peter McKenna

Jenna Hewitt

Lucy Finlay

Ravi Deevi

Patrick H O’ruane

Tom Biancardi

Thakur Raghu Raj Singh

David Waite

The Research Team at Re-Vana Therapeutics is dedicated to advancing the science behind long-acting biodegradable drug delivery systems for ocular applications. Comprising experts in various scientific disciplines, the team conducts innovative research and development to discover and optimize formulations and delivery methods targeting chronic eye diseases. Their work aims to enhance patient outcomes by improving the efficacy and convenience of ocular therapies.

Research Team

Advisory Team

Leadership Team

Research Team

About

Team members

Other teams at Re-Vana Therapeutics

Advisory Team

Leadership Team